RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 87 - per page Next page
Order by
Apitoxin - new biological drug for pain & inflammation and arthritis
Apitoxin is a new biological drug for pain & inflammation and arthritis, approved by the Korean FDA on May 3, 2003 after 14 years of preclinical, animal, and phase I, II & III clinical studies More
Genexol PM
Breast Cancer, Lung cancer, Pancreatic caner(cytotoxic chemotheraphy) More
Production process of C4 synthons by biotransformation._Enzytech
Production process of C3 synthons by biotransformation. More
Human Myeloma Cell Lines and their expansion (06-03)
Different myeloma tumor cell lines and their expansion for use in drug screening and research More
1. Anti-Cancer Agent(AG60), Anti-Hepatitis, Anti-Fibrotic Agent, Anti-BPH Agent, Anti-Hypertensive & Cholesterol Lowering Agent, Anti-Cataract Agent_Medvill
2. Anti-Atopic Dermatitis Cosmetics, Anti-Acne Cosmetics, Anti-Oxidants Vitaplus More
Blood Group Genotyping: Primers for RHD and ABO Gene Amplification
Blood Group Genotyping: Primers for RHD and ABO Gene Amplification More
Development of Corticotropin-Releasing Factor Overproducing Transgenic Mice
Development of Corticotropin-Releasing Factor Overproducing Transgenic Mice More
SNPper, Web-Based System for Retrieval and Analysis of Human Single Nucleotide Polymorphisms
SNPper, Web-Based System for Retrieval and Analysis of Human Single Nucleotide Polymorphisms More
Carbon Nanotube Transistor-Based Microarray Binding Sensors: Sequencing of DNA and Identification of miRNA Levels in Cancer
Carbon Nanotube Transistor-Based Microarray Binding Sensors: Sequencing of DNA and Identification of miRNA Levels in Cancer More
CRASA Annotation of Human Genome and CRASA Web Server: Analysing and Annotating Large Genomic Sequences
CRASA Annotation of Human Genome and CRASA Web Server: Analysing and Annotating Large Genomic Sequences More
Displaying 1..10 of 87 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Endothelin A Receptor Antagonist (atrasentan) Fails to Demonstrate an Advantage in the Treatment of Advanced Prostate Cancer
May 2011 - 5 pages - $500
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
Oct 2011 - 103 pages - $3,500
National Institute on Drug Abuse – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Cushing's Syndrome - Pipeline Review, Q4 2010
Dec 2010 - 33 pages - $500
Hyperphosphatemia - Pipeline Review, Q4 2010
Dec 2010 - 43 pages - $500
The Drug Discovery Outsourcing Market
Jan 2011 - 99 pages - $3,835
Epigenetics: Current and future applications that are driving novel drug discovery
Aug 2010 - 80 pages - $1,215
Nucleic Acid Drug Delivery Technologies: Players, products & prospects to 2018 (Volume III)
Jun 2009 - 110 pages - $1,040
Cushing's Syndrome - Pipeline Review, H2 2011
Aug 2011 - 52 pages - $500
III. Medizinische Klinik – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 27 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us